SEC Form 4 · accession 0001209191-15-046170
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhenwei Miao
Officer — SVP, Head of ADC Development
Period of report
May 21, 2015
Accepted (ET)
May 22, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 21, 2015 | G | 40,000 | $0.00 | D | 559,390 | D |
Table II — derivative securities
No Table II lines on this filing.